Vanguard reports 2.66M Axogen stake (NASDAQ: AXGN)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Vanguard Capital Management reports beneficial ownership of 2,659,776 shares of Axogen Inc common stock, representing 5.12% of the class.
The Schedule 13G states Vanguard has sole voting power for 368,213 shares and sole dispositive power for 2,659,776 shares. The filing attributes holdings to Vanguard funds and managed accounts. The form is signed 04/29/2026.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 2,659,776 shares
Percent of class: 5.12%
Sole voting power: 368,213 shares
+3 more
6 metrics
Shares beneficially owned
2,659,776 shares
Amount beneficially owned reported on Schedule 13G
Percent of class
5.12%
Percent of Axogen common stock class reported
Sole voting power
368,213 shares
Number with sole power to vote or direct the vote
Sole dispositive power
2,659,776 shares
Number with sole power to dispose or direct disposition
Reporting period date
03/31/2026
Date shown on cover line for the filing
Signature date
04/29/2026
Signed by Head of Global Fund Administration
Key Terms
beneficially owned, sole dispositive power, Schedule 13G
3 terms
beneficially owned regulatory
"this reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 2659776"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"Item 1. | (a) | Name of issuer: Axogen Inc ... Schedule 13G"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
FAQ
What stake does Vanguard Capital Management report in AXGN?
Vanguard reports beneficial ownership of 2,659,776 shares of Axogen common stock, equal to 5.12% of the class. The position combines holdings across Vanguard funds and managed accounts under Vanguard Capital Management's dispositive authority.
What voting and disposition powers does Vanguard hold for AXGN?
The filing shows Vanguard has sole voting power for 368,213 shares and sole dispositive power for 2,659,776 shares. Shared voting or dispositive powers are reported as 0 in this Schedule 13G.
When was the Schedule 13G for AXGN signed and filed?
The Schedule 13G excerpt is signed by Ashley Grim, Head of Global Fund Administration, with the signature date of 04/29/2026. The report references holdings as of 03/31/2026 on the cover line.